Expression of prostaglandin E synthase mRNA is induced in beta-amyloid treated rat astrocytes

Neuroscience Letters

Volumn 283, Issue 3, 2000, Pages 221-223

  Satoh, Kazuki ^a   Nagano, Yuki ^a   Shimomura, Chieko ^a   Suzuki, Nobuyuki ^a   Saeki, Yoshiyuki ^a   Yokota, Hiroshi ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Alzheimer's disease; Beta amyloid; cDNA subtraction; Prostaglandin E2; Rat astrocyte

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; SYNTHETASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; ENZYME INDUCTION; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEQUENCE ANALYSIS; SHORT SURVEY;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; CELLS, CULTURED; ENZYME INDUCTION; INTRAMOLECULAR OXIDOREDUCTASES; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RATS; RATS, WISTAR; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0034646925     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00926-5     Document Type: Article

References (23)

1. Andersen K., Launer L.J., Ott A., Hose A.W., Breteler M.M.B., Hofman A. Do non-steroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotteerdam study, Neurology. 45:1995;1441-1445.
2. Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J., Anthony J.C. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
3. Cotman C.W., Tenner A.J., Cummings B.J. β-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging. 17:1996;723-731.
4. Dickson D.W. The pathogenesis of senile plaques. J. Neuropathol. Exp. Neurol. 56:1997;321-339.
5. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van de Putte L.B.A., Lipsky P.E. Cyclioxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
6. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
7. 2. FASEB J. 5:1991;2575-2581.
8. Hershman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299:1996;125-140.
9. 2α to conscious mice. Eur. J. Pharmacol. 122:1986;173-179.
10. Hu J., Akama K.T., Krafft G.A., Chromy B.A., Van Eldik L.J. Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785:1998;195-206.
11. Jakobsson P.-J., Thoren S., Morgenstern R., Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target, Proc. Natl. Acad. Sci. USA. 96:1999;7220-7225.
12. Kato T., Chiu T.C., Lim R., Troy S.S., Turriff D.E. Multiple molecular forms of glia maturation factor. Biochim. Biophys. Acta. 579:1979;216-227.
13. Kitamura Y., Shimohama S., Koike H., Kakimura J., Matsuoka Y., Nomura Y., Gebicke-Haerter P.J., Taniguchi T. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brains. Biochem. Biophys. Res. Commun. 254:1999;582-586.
14. Landolifi C., Solo L., Polenzani L. Inflammatory molecule release by beta-amyloid-treated T98G astrocytoma cells: role of prostaglandins and modulation by paracetamol. Eur. J. Pharmacol. 360:1998;55-64.
15. Mark R.E., Sheng J.G., Griffin S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol. 26:1995;816-823.
16. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implication for therapy of Alzheimer and other neurondegenerative diseases. Brain Res. Rev. 21:1995;195-218.
17. Meade E.A., Smith W.L., Dewitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:1993;6610-6614.
18. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J. Selectivity of non-steroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 90:1994;11693-11697.
19. 2 levels in patients with probable AD. Neurology. 53:1999;1495-1498.
20. Pasinetti G.M., Aisen P.S. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience. 87:1998;319-324.
21. Pike C.J., Ramezan-Arab N., Miller S., Cotman C.W. β-amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes. Exp. Neurol. 139:1996;167-171.
22. 3. Nature (Lond.). 395:1998;281-284.
23. Yanker B.A. Mechanisms of neuronal degeneration in Alzheimer's diseases. Neuron. 16:1996;921-932.